Encephalopathy future or investigational therapies

Encephalopathy
Home
Patient Information
Overview
Classification
Pathophysiology
Causes
Differentiating Encephalopathy from other Diseases
Epidemiology & Demographics
Risk Factors
Screening
Natural History, Complications & Prognosis
Diagnosis
Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Electroencephalogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Encephalopathy future or investigational therapies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Encephalopathy future or investigational therapies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Encephalopathy future or investigational therapies
CDC on Encephalopathy future or investigational therapies
Encephalopathy future or investigational therapies in the news
Blogs on Encephalopathy future or investigational therapies
Directions to Hospitals Treating Encephalopathy
Risk calculators and risk factors for Encephalopathy future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2]

Overview

Newer investigational and therapeutic modalities are under consideration.

New Therapies

Newer modalities of treatment are considered for hypoxic encephalopathy. These drugs reduce the brain activity and its oxygen requirements.

• Magnesium - blocks NMDA receptor
• Adenosine - decreases glutamate release
• Vitamin C - reduces free radicals
• Caspase inhibitors - Inhibit apoptosis and prevents death of brain tissue